LITTLE et al v. MENTOR WORLDWIDE LLC
Filing
39
ORDER granting (36) Motion for Summary Judgment in case 4:13-cv-00244-CDL; granting (36) Motion for Summary Judgment in case 4:13-cv-00245-CDL. Ordered by US DISTRICT JUDGE CLAY D LAND on 08/15/2016. (CCL)
IN THE UNITED STATES DISTRICT COURT
FOR THE MIDDLE DISTRICT OF GEORGIA
COLUMBUS DIVISION
IN RE MENTOR CORP. OBTAPE
TRANSOBTURATOR SLING PRODUCTS
LIABILITY LITIGATION
* MDL Docket No. 2004
4:08-MD-2004 (CDL)
*
Case No.
* 4:13-cv-244 (Little)
* 4:13-cv-245 (Winchester)
O R D E R
Defendant
Mentor
Worldwide
LLC
developed
a
suburethral
sling product called ObTape Transobturator Tape, which was used
to treat women with stress urinary incontinence.
Plaintiffs
Janice Little and Julie Winchester were implanted with ObTape.
Each
Plaintiff
ObTape.
asserts
that
she
suffered
injuries
caused
by
Plaintiffs brought product liability actions against
Mentor, contending that ObTape had design and/or manufacturing
defects that proximately caused their injuries.
assert
that
Mentor
did
not
adequately
warn
about the risks associated with ObTape.
Plaintiffs also
their
physicians
Mrs. Little’s husband
James asserts a loss of consortium claim.
Mentor seeks summary
judgment
contending
on
all
of
Plaintiffs’
claims,
claims are time-barred under Oklahoma law.
that
the
For the reasons set
forth below, the Court agrees, and Mentor’s summary judgment
motions (ECF No. 36 in 4:13-cv-244 and ECF No. 36 in 4:13-cv245) are granted.1
SUMMARY JUDGMENT STANDARD
Summary judgment may be granted only “if the movant shows
that there is no genuine dispute as to any material fact and the
movant is entitled to judgment as a matter of law.”
Civ. P. 56(a).
In determining whether a
genuine
Fed. R.
dispute of
material fact exists to defeat a motion for summary judgment,
the evidence is viewed in the light most favorable to the party
opposing summary judgment, drawing all justifiable inferences in
the opposing party’s favor.
477 U.S. 242, 255 (1986).
Anderson v. Liberty Lobby, Inc.,
A fact is material if it is relevant
or necessary to the outcome of the suit.
Id. at 248.
A factual
dispute is genuine if the evidence would allow a reasonable jury
to return a verdict for the nonmoving party.
Id.
FACTUAL BACKGROUND
I.
Factual Background – Mr. and Mrs. Little
On April 24, 2006, Dr. Clifton Whitesell implanted Mrs.
Little with ObTape to treat her stress urinary incontinence.
At
the time, Dr. Whitesell was not aware that Mentor had stopped
selling
ObTape
in
March
2006.
Mrs.
Little’s
incontinence
symptoms improved, and her incision was healing nicely.
1
But in
Winchester and the Littles assert their claims separately in two
independent civil actions.
Because the resolution of the summary
judgment motions in both actions involves similar issues of Oklahoma
law, the Court decides both motions in this single order.
2
late 2006, Mrs. Little experienced painful intercourse with her
husband, and Mr. Little was cut by the sling.
At that point,
Mrs. Little realized that something had gone wrong.
Mrs. Little returned to Dr. Whitesell in December 2006 and
reported recurrent stress urinary incontinence, abdominal pain,
and
painful
intercourse.
Dr.
Whitesell
suspected
that
Mrs.
Little’s sling was causing her problems and that he might need
to remove it.
Little,
and
removed.
Dr. Whitesell discussed his suspicion with Mrs.
she
decided
that
she
wished
to
have
the
sling
Dr. Whitesell examined Mrs. Little under anesthesia,
determined that the sling had failed, and removed the sling.
Dr. Whitesell told Mrs. Little that he had removed the sling
because he believed it was causing her pain symptoms.
Little
acknowledges
that
she
understood
that
the
sling
Mrs.
had
failed and was causing problems; she hoped that removing the
sling would cure her symptoms.
After the December 2006 removal
of Mrs. Little’s ObTape, Mrs. Little’s abdominal pain resolved,
and she was able to resume normal sexual relations with her
husband.
Her stress urinary incontinence worsened, however.
In
2007, Dr. Whitesell implanted Mrs. Little with a different kind
of sling.
See Little Dep. 189:11-16, ECF No. 36-5 (stating that
Dr. Whitesell “certainly wasn’t going to use the one he had
previously used [ObTape] because that one had failed and was -something was wrong”).
Mrs. Little asserts that she did not
3
suspect that her problems might be related to a defect in ObTape
until she saw a television commercial regarding mesh implant
complications in 2013.
Mrs. Little asserts claims for negligence, strict liability
(design
defect,
breach
of
manufacturing
express
fraudulent
and
failure
breach
of
implied
warranty,
misrepresentation,
negligent
fraudulent
misrepresentation.
consortium claim.
to
defect,
summary
Mr.
Little
to
warn),
warranty,
concealment,
asserts
a
loss
and
of
Mrs. Little concedes that Mentor is entitled
judgment
on
her
breach
of
warranty
claims,
and
summary judgment is thus granted as to those claims.
II.
Factual Background – Winchester
On September 1, 2004, Dr. Gregory Jia implanted Winchester
with ObTape to treat her stress urinary incontinence.
Several
months after her implant surgery, Winchester began to experience
pelvic
cramps
examined
and
Winchester
Dr.
malodorous
vaginal
and
could
feel
Jia
believed
discharge.
the
that
Dr.
sling.
her
sling
Jia
Winchester
understood
that
had
become
infected.
Winchester Dep. 184:6-11, ECF No. 37-5 (“[Dr. Jia]
believed that the infection got onto the sling, so he took that
sling out and put a new sling in.”).
In November 2005, Dr. Jia
removed Winchester’s ObTape and implanted a new ObTape.
A
couple
Winchester
began
months
to
after
the
experience
4
second
vaginal
implant
drainage
surgery,
again.
She
visited Dr. Sherry Thomas, who diagnosed Winchester with a sling
erosion and infection in July 2006.
that
the
sling
removed.
was
infected
Dep.
Thomas
an
129:5-7,
Dr. Thomas told Winchester
foreign
ECF
body
No.
and
36-7.
had
to
be
Winchester
understood that Dr. Thomas was planning to remove her ObTape.
Dr. Thomas removed Winchester’s second ObTape on July 19, 2006.
At some point, Winchester asked Dr. Thomas if the sling could be
causing her infections.
According to Winchester, Dr. Thomas
said “she didn’t believe so because she had put several in and
had nothing like this happen to them . . . so she believed that,
she took the foreign body out . . . and was going to let my
vagina wall heal.”
Winchester Dep. at 261:10-16.
Winchester
acknowledges that she never asked Dr. Thomas why her ObTape
implants
had
not
been
a
success
even
though
success with the product in other patients.
Dr.
Thomas
had
Id. at 205:5-12.
Winchester asserts that she did not suspect that her problems
might
be
related
to
a
defect
in
ObTape
until
she
saw
a
television commercial on mesh implant complications in 2012.
Winchester asserts claims for negligence, strict liability
(design
defect,
breach
of
fraudulent
manufacturing
express
defect,
and
failure
breach
of
implied
warranty,
misrepresentation,
negligent misrepresentation.
fraudulent
to
warn),
warranty,
concealment,
and
Winchester concedes that Mentor is
5
entitled to summary judgment on her breach of warranty claims,
and summary judgment is thus granted as to those claims.
DISCUSSION
The
Littles
and
Winchester
filed
their
actions
in
this
Court on July 9, 2013 under the Court’s direct filing order.
The parties agreed that for direct-filed cases, the “Court will
apply the choice of law rules of the state where the plaintiff
resides at the time of the filing of the complaint.”
Order
Regarding Direct Filing § II(E), ECF No. 446 in 4:08-md-2004.
Plaintiffs lived in Oklahoma when they filed their actions, and
all
of
Plaintiffs’
ObTape-related
The
agree
Oklahoma.
parties
that
treatment
Oklahoma
took
law
place
in
applies
to
Plaintiffs’ claims.
Oklahoma has a two-year statute of limitations for product
liability claims.
Okla. Stat. tit. 12, § 95(3); Kirkland v.
Gen. Motors Corp., 521 P.2d 1353, 1361 (Okla. 1974); Fuchs v.
Fleetwood Homes of Texas, 149 P.3d 1099, 1101–02 (Okla. Civ.
App.
2006).
statute
of
Plaintiffs
limitations
do
not
applies
dispute
to
their
that
this
two-year
negligence,
strict
liability, fraud, and misrepresentation claims. They contend,
however,
that
their
claims
did
not
accrue
under
Oklahoma’s
discovery rule until they saw a television advertisement about
mesh complications shortly before they filed their actions.
6
Under Oklahoma’s discovery rule, the statute of limitations
for a product liability action begins to run when “the plaintiff
knows, or as a reasonably prudent person should know, that he
has
the
condition
for
which
his
action
is
brought
and
that
defendant has caused it.” Williams v. Borden, Inc., 637 F.2d
731,
734
(10th
Cir.
1980)
(applying
Oklahoma
law);
accord
Daugherty v. Farmers Co-op. Ass’n, 689 P.2d 947, 950–51 (Okla.
1984) (confirming that Oklahoma applies the discovery rule in
product liability actions).
The discovery rule applies when a
plaintiff, “despite the exercise of due diligence, [is unable]
to know of the injury or its cause.”
Resolution Trust Corp. v.
Grant, 901 P.2d 807, 813 (Okla. 1995).
“The purpose of the rule
is to exclude the period of time during which the injured party
is reasonably unaware that an injury has been sustained so that
people in that class have the same rights as those who suffer an
immediately ascertainable injury.”
Id.
Once a plaintiff knows
or should know of a connection between the defendant’s product
and her injuries, she “is required to pursue [her] claim with
diligence.”
limitation
Daugherty,
were
not
689
designed
P.2d
to
at
help
inquiries
951.
those
plainly
“Statutes
who
of
negligently
refrain
from
prosecuting
suggested
by
the
facts.”
Id.
“A plaintiff is chargeable with knowledge of facts
which he ought to have discovered in the exercise of reasonable
diligence.”
Id.
7
In Borden, the Tenth Circuit predicted that the Oklahoma
Supreme
Court
would
liability actions.
apply
the
discovery
rule
in
product
The plaintiff in Borden developed asthma and
believed that her condition was caused by polyvinyl chloride
fumes she inhaled at her workplace.
At the time, the medical
community had not yet discovered that the fumes could cause
asthma.
not
The Tenth Circuit found that the plaintiff’s claim did
accrue
causation.
until
she
Borden,
could
637
F.2d
obtain
at
some
733–34.
medical
In
proof
Daugherty,
on
the
Oklahoma Supreme Court stated that the Tenth Circuit in Borden
“correctly predicted [the Oklahoma Supreme Court’s] approval of
the
discovery
rule
in
those
cases
applying
limitations to products liability actions.”
at 950.
the
statute
of
Daugherty, 689 P.2d
The Daugherty court warned, however, that the discovery
rule “must not be interpreted as broadly as could be inferred
from
Borden.”
Id.
The
Daugherty
court
emphasized
that
in
Borden, “a reasonably prudent person could not have discovered
the cause of the” asthma because the medical community had not
yet determined that PVC fumes could cause asthma.
words,
the
Borden
plaintiff
“had
no
way
of
Id.
In other
attributing
symptoms to an injury which defendant’s product caused.”
The
Daugherty
court
further
stated:
“Properly
limited,
his
Id.
a
discovery rule should encompass the precept that acquisition of
sufficient information which, if pursued, would lead to the true
8
condition of things will be held as sufficient knowledge to
start the running of the statute of limitations.”
Id. at 950-
951.
In
Daugherty,
injuries
caused
plaintiff’s
the
by
doctor
plaintiff
exposure
diagnosed
asserted
to
toxic
the
that
he
suffered
pesticides.
plaintiff
with
The
pesticide
toxicity, and that is when “the connection between the product
and the injury was discoverable.”
Id. at 950.
At that point,
“the circumstances were such as to put a reasonable man upon
inquiry,” and the plaintiff was “chargeable with the knowledge
such
inquiry
plaintiff
did
would
not
have
produced.”
pursue
a
claim
Id.
at
951.
against
the
But
the
insecticide
manufacturer until nearly three years after his diagnosis, and
the Oklahoma Supreme Court concluded that his claims were barred
because the record showed that he had enough facts “to put a
reasonable man upon inquiry” years before he filed his action.
Id.
Here,
connection
Plaintiffs
between
advertisements
argue
ObTape
regarding
that
and
mesh
they
their
did
not
injuries
complications
in
learn
until
2012
of
they
or
a
saw
2013.
But each Plaintiff knew that she suffered some injuries related
to ObTape well before then.
By late 2006, Mrs. Little understood that her ObTape had
failed and was causing problems, and she hoped that removing the
9
sling would cure her symptoms.
After Mrs. Little’s ObTape was
removed in December 2006, her abdominal pain and dyspareunia
symptoms resolved.
And when Mrs. Little underwent another sling
implant surgery in 2007, she received a different type of sling
because her doctor “certainly wasn’t going to use the one he had
previously used [ObTape] because that one had failed and was -something was wrong.”
Little Dep. 189:11-16.
In sum, Mrs.
Little should have been on notice of a connection between at
least some of her symptoms and ObTape by December 2006.
By July 2006, Winchester had suffered an ObTape erosion.
She knew that her sling was infected and needed to be removed
from her body.
the
sling
Winchester asserts that she asked Dr. Thomas if
could
be
causing
some
of
her
infections,
and
Dr.
Thomas said “she didn’t believe so because she had put several
in
and
had
nothing
like
this
happen
to
them
. . .
so
she
believed that, she took the foreign body out . . . and was going
to let my vagina wall heal.”
Winchester Dep. at 261:10-16.
Although Dr. Thomas did not tie some of Winchester’s infections
to
ObTape,
including
ObTape.
she
the
For
did
attribute
erosion
these
some
through
reasons,
of
Winchester’s
Winchester’s
Winchester
vaginal
should
have
injuries—
wall—to
been
on
notice of a connection between at least some of her symptoms and
ObTape by July 2006.
10
In
summary,
Mrs.
Little
and
Winchester
knew
of
or
had
enough information to know of a connection between ObTape and at
least some of their injuries by 2006.
A reasonable person in
that situation would take some action to follow up on the cause
of her injuries and try to find out whether the injuries were
caused by a problem with ObTape, a problem with the implant
surgery, or some other problem.
any
evidence
that
she
Mrs. Little did not point to
exercised
investigate her potential claims.
reasonable
diligence
Nor did Winchester.
to
Although
Winchester asked one doctor if her infection symptoms might be
caused by ObTape and was told that the doctor did not think so
because she had a good record of success with ObTape, Winchester
knew that the ObTape had eroded through her vaginal wall and had
to
be
removed
so
she
could
heal.
In
other
words,
while
Winchester pointed to evidence that she attempted to follow up
on
a
suspected
connection
between
ObTape
and
some
of
her
symptoms, she did not point to evidence that she attempted to
follow up on the erosion injuries, which she knew or should have
known were related to ObTape.
Plaintiffs also did not point to
evidence that they could not have discovered enough facts to
support their product liability and misrepresentation claims had
they
started
investigating
the
connection
they
made
(or
had
enough information to make) between ObTape and their injuries
within a reasonable time after they discovered the connection.
11
Plaintiffs filed their actions more than six years after
they knew or should have known that at least some of their
symptoms were connected to ObTape.
statute
of
limitations
fraudulently
concealed
should
from
Plaintiffs argue that the
be
tolled
Plaintiffs
because
that
Mentor
ObTape
was
defective, so Plaintiffs could not have been on notice in 2006
that a defect in ObTape caused their injuries.
Plaintiffs did
not point to any Oklahoma authority holding that a plaintiff
must be on actual notice that her injuries were caused by a
product defect.2
Rather, the precedent establishes that a claim
accrues when the plaintiff becomes aware of an injury and a
causal
connection
between
the
injury
and
the
defendant’s
product. See Daugherty, 689 P.2d at 950 (finding that statute of
limitations
product
began
and
fraudulent
the
to
run
injury
concealment
when
was
only
“the
connection
discoverable”).
applies
when
a
between
the
Furthermore,
party
wrongfully
conceals material facts to prevent discovery of the cause of
action.
Masquat v. DaimlerChrysler Corp., 195 P.3d 48, 54–55
(Okla. 2008).
“The ‘mere failure to disclose such material
2
Winchester cites the Court’s Order in Dover v. Mentor Corp., 711 F.
Supp. 2d 1348, 1379-80 (M.D. Ga. 2010), to support her argument that
the statute of limitations did not accrue until she had notice of a
defect in ObTape. But Dover was decided under Georgia law, and as the
Court has explained since it decided Dover, the Georgia notice
principle regarding the statute of limitations is distinguishable from
the law of other states, including Oklahoma.
See Bergin v. Mentor
Worldwide, LLC, No. 4:13-cv-135, 2016 WL 3049491, at *1 (M.D. Ga. May
27, 2016).
12
facts is not sufficient to prevent the running of the statute;
but when there is something more than mere failure to disclose,
when there is some actual artifice or some affirmative act of
concealment, or some misrepresentation which induces the other
party to inaction, or to forgo inquiry, the guilty party may not
cover up the harm he has thus wrought by aid of the statute of
limitations.’”
Shoemaker,
Id.
63
P.2d
(quoting
960,
961
Loyal
(Okla.
Protective
1936).
Ins.
“One
Co.
v.
relying
on
fraudulent concealment to toll the statute of limitations must
not only show that he did not know the facts constituting a
cause of action, but that he exercised reasonable diligence to
ascertain said facts.”
Id. (quoting Kansas City Life Ins. v.
Nipper, 51 P.2d 741, 742 (Okla. 1935)).
“‘[I]f the means of
knowledge exist and the circumstances are such as to put a man
of ordinary prudence on inquiry, it will be held that there was
knowledge of what could have been readily ascertained by such
inquiry’ and a plaintiff cannot successfully assert fraudulent
concealment
limitations.”
in
answer
to
the
defense
of
the
statute
of
Id. (quoting Nipper, 51 P.2d at 747).
Here, Plaintiffs contend that Mentor failed to disclose the
true risks of ObTape prior to their implant surgeries.
And Mrs.
Little asserts that Mentor failed to disclose that ObTape had
been withdrawn from the market by the time she was implanted
with it.
But Plaintiffs did not point to any affirmative act of
13
concealment or any misrepresentation by Mentor that induced them
not
to
investigate
injuries.
the
connection
between
ObTape
and
their
Again, by 2006, both Mrs. Little and Winchester knew
or should have known that at least some of their symptoms were
connected to ObTape.
At that point, they had a duty to exercise
reasonable diligence to investigate their potential claims.
they did not.
But
For all of these reasons, Plaintiffs’ claims are
time-barred.
Mr. Little’s loss of consortium claim is derivative of Mrs.
Little’s claims; because her underlying claims fail, his loss of
consortium claim also fails. Laws v. Fisher, 513 P.2d 876, 878
(Okla. 1973).
CONCLUSION
As discussed above, Mentor’s summary judgment motions (ECF
No.
36
in
4:13-cv-244
and
ECF
No.
36
in
4:13-cv-245)
are
granted.
IT IS SO ORDERED, this 15th day of August, 2016.
s/Clay D. Land
CLAY D. LAND
CHIEF U.S. DISTRICT COURT JUDGE
MIDDLE DISTRICT OF GEORGIA
14
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?